How Masteron Affects SHBG

Sex hormone binding globulin is produced by the liver and binds circulating androgens with high affinity, leaving only a small free fraction biologically active. Masteron affects it in two ways:

1. Hepatic SHBG suppression: All exogenous androgens suppress hepatic SHBG synthesis in a dose-dependent way. Dihydrotestosterone and its derivatives are particularly effective at this: DHT binds SHBG with the highest affinity of any endogenous androgen and suppresses its hepatic production strongly. Drostanolone is a DHT derivative and behaves accordingly, though the magnitude has not been measured in a trial.

2. Competition for binding sites: Because DHT derivatives bind SHBG tightly, drostanolone occupies binding sites that would otherwise carry testosterone. Displacing testosterone from SHBG increases its free fraction without changing total testosterone at all. This is a direct, immediate effect that operates independently of the slower hepatic suppression.

3. Why this matters clinically: The combination of lower SHBG production and competition for the remaining binding sites means a man running masteron alongside testosterone has a higher free testosterone than his total testosterone would suggest. This is the mechanism behind masteron's reputation for making a testosterone base feel stronger, and it is one of the more plausible of the compound's folk claims.

4. The interpretive consequence: total testosterone becomes a poor guide to androgen exposure on a masteron-containing cycle. Free testosterone or calculated free testosterone is required.

Evidence quality: The mechanism is well established for DHT and DHT derivatives as a class. It has not been quantified for drostanolone specifically in any published human study.

Masteron added to a testosterone base (typical use, 300-600 mg/week):

• SHBG falls further than testosterone alone would produce. A stack that had SHBG at 20 nmol/L on testosterone may drop to 10 nmol/L or below with masteron added.
• Free testosterone rises disproportionately, both from the lower SHBG and from displacement off the remaining binding sites.
• Total testosterone is unchanged by the masteron. Only the distribution changes.

With an oral 17-alpha-alkylated compound also in the stack:

• SHBG can fall below 5 nmol/L, sometimes to the limit of assay detection. Oxandrolone in particular suppresses SHBG aggressively.
• At that point, total testosterone readings carry almost no information.

Timing: The propionate ester reaches steady state within a week, and hepatic SHBG suppression follows over 1 to 2 weeks. The binding competition effect is immediate.

Recovery: SHBG recovers over 4 to 8 weeks after the compound clears, and drostanolone propionate clears within days.

Reference context: normal male SHBG is roughly 18 to 54 nmol/L. Values below 10 nmol/L on cycle are common and are not in themselves pathological.

Always order SHBG alongside total testosterone on a masteron-containing cycle. Without it, the total testosterone number is close to uninterpretable.

Add free testosterone:

• Equilibrium dialysis is the reference method.
• Calculated free testosterone from total testosterone, SHBG and albumin is acceptable, much cheaper, and adequate for tracking.

Interpretation:

• Low SHBG with high free testosterone and no symptoms of androgen excess is a working protocol.
• Low SHBG with high free testosterone and rising haematocrit, acne, aggression or oily skin argues for a dose reduction somewhere in the stack.
• An SHBG that was already low before any compound was added points at insulin resistance and warrants fasting insulin and HbA1c.

Do not chase SHBG as a target. It is a downstream marker of androgen exposure, and the only way to raise it is to reduce the exposure.

Post-cycle: SHBG recovery is a useful, cheap indicator that hepatic androgen signalling has normalised.

Use SHBG for interpretation, not as a problem to solve:

• The low SHBG is doing what masteron is being used for. It is the mechanism, not the side effect.

Watch the downstream consequences of a high free fraction:

• Haematocrit responds to androgen exposure, and a higher free testosterone means more exposure at the same total. Check the full blood count.
• DHT-mediated effects such as scalp shedding, acne and oily skin also track free androgen rather than total.

Reassess your dose using free testosterone, not total:

• Men on masteron-containing stacks routinely under-estimate their androgen exposure because they read total testosterone. A total of 25 nmol/L with an SHBG of 8 nmol/L is not the same exposure as 25 nmol/L with an SHBG of 35 nmol/L.

Address metabolic contributors off cycle:

• Insulin resistance suppresses SHBG independently. Improving insulin sensitivity through body composition and training raises SHBG through an unrelated pathway.

Further reading: Reading the total testosterone to oestradiol ratio